KALA BIO, Inc. (KALA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.56M | -85.2% |
| 2024 | $51.18M | +0.6% |
| 2023 | $50.90M | -27.8% |
| 2022 | $70.50M | -23.5% |
| 2021 | $92.14M | +19.2% |
| 2020 | $77.26M | -9.6% |
| 2019 | $85.45M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $7.56M | -85.2% |
| 2024 | $51.18M | +0.6% |
| 2023 | $50.90M | -27.8% |
| 2022 | $70.50M | -23.5% |
| 2021 | $92.14M | +19.2% |
| 2020 | $77.26M | -9.6% |
| 2019 | $85.45M | — |